Global M&A activity continues to show how companies are using acquisitions to accelerate growth, expand into new markets, strengthen product portfolios and improve long-term competitiveness. From KONE’s proposed combination with TK Elevator to Shell’s acquisition of ARC Resources and major pharmaceutical deals by Sun Pharma, Eli Lilly and Chiesi, recent transactions highlight a clear trend: companies are buying scale, capabilities and strategic assets that would take years to build organically.
Below are the top five M&A deals announced in the week ending April 26th, 2026. The data is curated from the Intellizence mergers & acquisitions Dataset.
| Acquiring Company | Acquired Company | Deal Size |
|---|---|---|
| Kone | TKE | $34.4 billion |
| Shell | ARC Resources | $16.4 billion |
| Sun Pharmaceutical Industries | Organon | $11.75 billion. |
| Eli Lilly & Co. | Ajax Therapeutics | $2.3 billion |
| Apollo | Forvia’s Auto Interiors Unit | $2.1 Billion |
1. KONE to Acquire TK Elevator in a €29.4 Billion Deal
Finnish elevator and escalator company KONE has agreed to acquire German rival TK Elevator in a transaction valuing TKE at €29.4 billion. The transaction includes cash, newly issued KONE shares and the refinancing of TKE’s existing debt. KONE said the combination would bring together two major players in the global elevator and escalator industry, with TKE contributing significant scale, service operations and global reach.
The acquisition would help expand KONE’s global footprint and strengthen its position in installation, maintenance and modernization services.
2. Shell to Acquire ARC Resources in a $16.4 Billion Energy Deal
Shell will acquire Canada-based ARC Resources, an energy company focused on the Montney shale basin in British Columbia and Alberta. The deal has an enterprise value of approximately $16.4 billion, including $13.6 billion in equity value and approximately $2.8 billion in net debt and leases. ARC shareholders will receive a mix of cash and Shell shares.
The acquisition will strengthens Shell’s Canadian resource base and adds significant production from the Montney basin.
3. Sun Pharma to Acquire Organon for $11.75 Billion
Sun Pharmaceutical Industries has signed a definitive agreement to acquire Organon in an all-cash transaction valued at an enterprise value of $11.75 billion. Organon brings a global women’s health portfolio, established brands, general medicines and biosimilars across more than 140 countries. The acquisition will help Sun Pharma a much larger global platform and strengthens its presence in women’s health, established brands and biosimilars. Organon’s portfolio and international.
4. Eli Lilly to Acquire Ajax Therapeutics for Up to $2.3 Billion
Eli Lilly has agreed to acquire Ajax Therapeutics, a biopharmaceutical company developing next-generation JAK inhibitors for patients with myeloproliferative neoplasms. Ajax shareholders could receive up to $2.3 billion. The acquisition will strengthens Lilly’s oncology pipeline by adding Ajax’s highly selective Type II JAK2 inhibitor candidate, AJ1-11095. Ajax is focused on developing therapies for myeloproliferative neoplasms, including myelofibrosis and polycythemia vera. For Lilly, the deal provides access to a targeted blood cancer program with potential to address unmet needs in patients with MPNs.
5. Apollo Funds to Acquire Forvia’s Automotive Interiors Business for €1.82 Billion ($2.1 Billion)
Apollo Funds has agreed to acquire Forvia’s automotive interiors business for €1.82 billion, or approximately $2.1 billion. The unit supplies instrument panels, door panels and center console systems to automakers. It generated €4.82 billion in sales in 2025, representing nearly 18% of Forvia’s total revenue. For Apollo, the acquisition creates an opportunity to own a large automotive interiors platform with global operations, manufacturing capabilities and R&D assets.
What These M&A Signals Mean
These M&A announcements show that companies are making bold moves to secure growth, innovation, and strategic assets. M&A signals reveal strategic direction early.
- Scale consolidation.
- Energy security and resource expansion.
- Pharmaceutical portfolio expansion
- Private equity carve-out
- Strategic capability acquisition
For sales, customer success, risk, strategy, and market intelligence teams, M&A signals can help identify how companies are changing direction, where capital is flowing, and which sectors are preparing for the next phase of growth.
Track the Latest M&A and Divestment Signals with Intellizence
Intellizence helps teams track the latest the latest mergers, acquisitions, and divestment signals
across industries with curated, near real-time company intelligence. This helps you identify market moves, business opportunities, and strategic changes faster. Access M&A intelligence through the Web App, API, CSV, and AI Agent workflows.
From mergers and acquisitions to divestments, funding, leadership changes, layoffs, and business expansion, Intellizence helps you stay ahead of the signals that matter.
Frequently Asked Questions
What is Intellizence M&A Data?
Intellizence M&A Data provides curated and structured information on mergers, acquisitions, divestments, buyouts, spin-offs, going-private transactions and terminated deals. It helps teams track deal activity across industries, geographies and company types.
- How can businesses use M&A signals?
Businesses can use M&A signals to identify sales opportunities, monitor competitors, track industry consolidation, assess customer or vendor risk, and discover strategic investment themes. M&A activity often signals leadership changes, integration needs, technology spend and new market priorities.
- What types of M&A deals does Intellizence track?
Intellizence tracks acquisition announcements, merger agreements, divestitures, private equity buyouts, cross-border deals, spin-offs, going-private transactions, deal terminations and other corporate transaction signals.
- Who uses Intellizence M&A Data?
Sales teams, strategy teams, investment firms, market intelligence teams, corporate development teams, consulting firms, executive search firms and AI/data teams use Intellizence M&A Data to monitor company changes and act on market signals faster.
- How is Intellizence M&A Data delivered?
Intellizence M&A Data can be delivered through the Web App, API, CSV exports and AI Agent workflows through the Intellizence MCP Server.
Why should companies track terminated or fallen-through deals too?
Failed deals matter because they can signal strategic uncertainty, financing problems, regulatory friction, or management distraction. These are often valuable intelligence signals for risk, sales, and market-monitoring workflows.
Refreshed Daily